About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top ...

Nothing spoils the view of your artwork like the blinding reflection of the sun. Luckily, we have an easy solution to reduce ...

Known for their rich pigments, bright colours, and ability to adhere to many surfaces, they’re already long-lasting and ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

A controversial art installation at the Chicago Cultural Center has prompted criticism from 27 alderpeople, who called the piece anti-Semitic and asked for its removal. The exhibit critiques U.S ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...